Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
TITAN PHARMACEUTICALS INC has filed 1,052 SEC EDGAR filings since 15 May 1996

SEC filing history

Showing 251-275 of 686 matching filings.

Per page
25
Current page
11
DEFA14A File 001-13341

8-K

Filing date
05 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

FORM 8-K

Filing date
16 Jul 2020
Reporting date
16 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-13341

FORM 8-K

Filing date
16 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-13341

DEFA14A

Filing date
08 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-13341

DEFA14A

Filing date
29 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

FORM 8-K

Filing date
29 Jun 2020
Reporting date
29 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

FORM 8-K

Filing date
25 Jun 2020
Reporting date
23 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-13341

DEFA14A

Filing date
19 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-13341

DEF 14A

Filing date
22 May 2020
Reporting date
30 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-13341

PRE 14A

Filing date
12 May 2020
Reporting date
30 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

FORM 8-K

Filing date
24 Apr 2020
Reporting date
24 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

FORM 8-K

Filing date
19 Mar 2020
Reporting date
19 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

FORM 8-K

Filing date
16 Mar 2020
Reporting date
16 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

FORM 8-K

Filing date
02 Mar 2020
Reporting date
02 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-13341

DEFA14A

Filing date
24 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-13341

DEFA14A

Filing date
19 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-13341

DEFA14A

Filing date
12 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-13341

DEFA14A

Filing date
31 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-13341

DEF 14A

Filing date
31 Jan 2020
Reporting date
02 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-46083

TITAN PHARMACEUTICALS, INC.

Filing date
27 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-13341

PRE 14A

Filing date
21 Jan 2020
Reporting date
31 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-13341

FORM 8-K

Filing date
16 Jan 2020
Reporting date
16 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-46083

SABBY 13G-A TTNP 1.13.20

Filing date
13 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .